Ads
related to: merck & co. stock prices
Search results
Merck Halts Skin Cancer Drug Trial On High Discontinuation Rate - A Setback in High-Risk Melanoma...
Benzinga via Yahoo Finance· 1 hour agoMonday, Merck & Co Inc (NYSE:MRK) announced the discontinuation of the vibostolimab and...
Barrow, Hanley, Mewhinney & Strauss Bolsters Portfolio with Strategic Additions in Q1 2024
GuruFocus.com via Yahoo Finance· 1 hour agoThe stock traded at an average price of $42.20 during the quarter and has returned 6.48% over the...
Merck's (NYSE:MRK) investors will be pleased with their notable 90% return over the last three years
Simply Wall St. via Yahoo Finance· 3 days agoBut if you pick the right individual stocks, you could make more than that. For example, Merck & Co...
Investors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know
Zacks· 5 days agoFree Report) is one of the stocks most watched by Zacks.com visitors lately. Shares of this pharmaceutical company have returned +2.2% over the past month versus the Zacks S&P 500 composite's ...
Data-Based Insights About Merck & Co Inc
Stocks Register· 4 days agoMerck & Co Inc (NYSE:MRK) price on Thursday, May 09, rose 0.08% above its previous day’s close as an upside momentum from buyers pushed ...
Stocks of local interest
Clinton Herald, Iowa via Yahoo Finance· 3 days ago...976.06 Boeing 178.51 Bank of America 38.45 BP PLC ADR 37.84 ConAgra Foods 31.13 Caterpillar 354.79 Clorox 143.28 Chevron Texaco 165.82 Darling Int'l. 46.35 Deere & Co. 407.84 Dollar General 140.91 Walt Disney Co. 105.79 Ennis Business Forms 20.53 Eaton Corp. 330.57 Exelon 37.67 ...
Calliditas' survival data salvage midphase cancer trial after primary endpoint miss
FierceBiotech· 6 days agoCalliditas Therapeutics had a typical to-do list for its midphase head and neck cancer study. Step...
Dow Jones Today: Dow Extends Winning Streak to Eight Days as Major Indexes Gain For Third...
Investopedia· 3 days agoMettler Toledo (MTD) led gains among S&P 500 stocks Friday, soaring 17% following a strong quarterly...
Earnings call: Ginkgo Bioworks targets breakeven by 2026 with strategic cuts By Investing.com
Investing.com· 3 days agoGinkgo Bioworks Holdings Inc. (NYSE: NYSE:DNA), a leading biotech company, outlined a series of...
